It is a pharma private limited company based in Salem, Tamil Nadu, India, established in 2017.
2017 | Salem, Tamil Nadu, India | ActiveBiofloris Pharmaceuticals Private Limited, a active private limited company, was established on 28 September 2017 in Salem, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33300TZ2017PTC029531. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹6.00 M and a paid-up capital of ₹5.70 M.
It upholds a compliant status. Its leadership includes Karthikeyan Arjunan (Director), Muthu Chellappan Deivasigamani (Director), Balakrishnan Rajaganesan (Director). Past directors included Chinnaraju Manikandan, Mariappan Sukumar Sampathkumar, Nandhakumar Venkatachalam. It holds ₹6.30 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D No 28 Town Railway Station Road, Salem Town, Salem, Tamil Nadu, 636001.
U33300TZ2017PTC029531
029531
28 September 2017
₹6.00 M
₹5.70 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Biofloris Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Karthikeyan Arjunan | Director | 15 Jul 2019 | Current |
| Muthu Chellappan Deivasigamani | Director | 01 Dec 2017 | Current |
| Balakrishnan Rajaganesan | Director | 01 Dec 2017 | Current |
| Rajamanikkam Kandasamy | Director | 01 Dec 2017 | Current |
| Manickam Rajendran | Director | 01 Dec 2017 | Current |
| Premkumar Asokumar | Director | 01 Dec 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 19 Feb 2019 | Past |
| Pramod Abcsdd | Director | 27 Feb 2023 | Past |
| Pramod Abcsdd | Director | 27 Feb 2023 | Past |
| Pramod Abcsdd | Director | 19 Feb 2019 | Past |
| Pramod Abcsdd | Director | 19 Feb 2019 | Past |
| Pramod Abcsdd | Director | 27 Feb 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biofloris Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.05% increase. The company also saw a substantial improvement in profitability, with a 94.15% increase in profit. The company's net worth Soared by an impressive increase of 43.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Biofloris Pharmaceuticals had a public holding of 87.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2025 | Hdfc Bank Limited | ₹2.60 M | Open |
| 27 Sep 2024 | Hdfc Bank Limited | ₹3.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biofloris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biofloris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofloris Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.60 M with Charge ID 101122857 was registered on 27 Jun 2025. was documented.
The activity Biofloris Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.70 M with Charge ID 101000023 was registered on 27 Sep 2024. was documented.
Progress on Biofloris Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore. was documented.
Progress on Karthikeyan Arjunan was appointed as a Director was appointed as a Director on 15 Jul 2019 & has been associated with this company since 6 years 4 months . was documented.
Muthu Chellappan Deivasigamani was appointed as a Director was appointed as a Director on 01 Dec 2017 & has been associated with this company since 7 years 11 months . was recorded as a recent event.
The CIN of Biofloris Pharmaceuticals Private Limited is U33300TZ2017PTC029531.
Biofloris Pharmaceuticals Private Limited is headquartered at D No 28 Town Railway Station Road, Salem Town, Salem, Tamil Nadu, 636001.
Biofloris Pharmaceuticals Private Limited was incorporated on 28 September 2017.
The current directors of Biofloris Pharmaceuticals Private Limited are
The primary industry of Biofloris Pharmaceuticals Private Limited is Trade.
Biofloris Pharmaceuticals Private Limited is unlisted.
The authorized capital of Biofloris Pharmaceuticals Private Limited is ₹6.00 M, and the paid-up capital is ₹5.70 M.
The compliance status of Biofloris Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX